Strs Ohio Buys 17,400 Shares of Evolent Health, Inc. (NYSE:EVH)

Strs Ohio raised its stake in Evolent Health, Inc. (NYSE:EVHGet Rating) by 1,023.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,100 shares of the technology company’s stock after acquiring an additional 17,400 shares during the quarter. Strs Ohio’s holdings in Evolent Health were worth $686,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in shares of Evolent Health by 1.5% in the first quarter. Vanguard Group Inc. now owns 7,657,874 shares of the technology company’s stock worth $247,350,000 after acquiring an additional 111,882 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Evolent Health by 4.9% in the first quarter. BlackRock Inc. now owns 6,180,992 shares of the technology company’s stock worth $199,644,000 after acquiring an additional 291,029 shares during the last quarter. FMR LLC lifted its holdings in shares of Evolent Health by 31.3% in the second quarter. FMR LLC now owns 4,509,709 shares of the technology company’s stock worth $138,493,000 after acquiring an additional 1,076,092 shares during the last quarter. State Street Corp raised its holdings in Evolent Health by 2.0% in the 2nd quarter. State Street Corp now owns 1,688,370 shares of the technology company’s stock valued at $51,850,000 after buying an additional 33,112 shares during the last quarter. Finally, Millennium Management LLC raised its holdings in Evolent Health by 28.0% in the 2nd quarter. Millennium Management LLC now owns 1,344,003 shares of the technology company’s stock valued at $41,274,000 after buying an additional 294,239 shares during the last quarter. Institutional investors own 93.33% of the company’s stock.

Insider Transactions at Evolent Health

In other news, CEO Seth Blackley sold 75,000 shares of the firm’s stock in a transaction that occurred on Monday, November 21st. The shares were sold at an average price of $26.79, for a total transaction of $2,009,250.00. Following the completion of the sale, the chief executive officer now owns 422,037 shares of the company’s stock, valued at approximately $11,306,371.23. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Seth Blackley sold 75,000 shares of Evolent Health stock in a transaction on Monday, November 21st. The shares were sold at an average price of $26.79, for a total value of $2,009,250.00. Following the completion of the sale, the chief executive officer now owns 422,037 shares of the company’s stock, valued at approximately $11,306,371.23. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Frank J. Williams sold 110,000 shares of Evolent Health stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $29.32, for a total transaction of $3,225,200.00. Following the completion of the sale, the director now directly owns 626,479 shares of the company’s stock, valued at approximately $18,368,364.28. The disclosure for this sale can be found here. Insiders sold a total of 405,000 shares of company stock valued at $11,333,950 in the last quarter. 4.20% of the stock is currently owned by company insiders.

Evolent Health Stock Performance

Shares of EVH stock opened at $31.66 on Tuesday. The company has a market cap of $3.20 billion, a price-to-earnings ratio of -211.05 and a beta of 1.56. Evolent Health, Inc. has a 52 week low of $21.36 and a 52 week high of $39.78. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.48. The firm has a 50 day moving average of $27.15 and a 200-day moving average of $31.67.

Evolent Health (NYSE:EVHGet Rating) last announced its quarterly earnings data on Wednesday, November 2nd. The technology company reported $0.52 EPS for the quarter. The company had revenue of $352.59 million during the quarter, compared to the consensus estimate of $354.57 million. Evolent Health had a negative net margin of 1.11% and a positive return on equity of 8.83%. On average, equities analysts forecast that Evolent Health, Inc. will post 0.61 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on EVH shares. Canaccord Genuity Group dropped their price objective on shares of Evolent Health from $48.00 to $44.00 in a report on Thursday, November 3rd. StockNews.com lowered shares of Evolent Health from a “hold” rating to a “sell” rating in a report on Friday, November 4th. BTIG Research dropped their price objective on shares of Evolent Health from $55.00 to $45.00 and set a “buy” rating for the company in a report on Wednesday, October 12th. Piper Sandler raised their price target on shares of Evolent Health from $44.00 to $51.00 in a report on Friday, January 6th. Finally, Cowen raised their price target on shares of Evolent Health from $52.00 to $57.00 and gave the stock an “outperform” rating in a report on Friday, November 18th. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, Evolent Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $47.50.

About Evolent Health

(Get Rating)

Evolent Health, Inc, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.

See Also

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health, Inc. (NYSE:EVHGet Rating).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.